TerrAscend Stock (CSE: TER) (OTCQX: TRSSF) - Investor Dashboard

Summary

Financials (09/30/22)

Capital Structure (11/14/22)

TerrAscend is a leading North American cannabis operator with operations in Pennsylvania, New Jersey, California, Michigan and Maryland, in addition to operating as a licensed producer in Canada. TerrAscend operates an award-winning chain of Apothecarium dispensary retail locations as well as scaled cultivation, processing, and manufacturing facilities on both the East and West coasts. TerrAscend’s best-in-class cultivation and manufacturing practices yield consistent, high-quality cannabis, providing industry-leading product selection to both the medical and legal adult-use market.

The Company owns a number of synergistic businesses and brands, including The Apothecarium, Ilera Healthcare, State Flower, Valhalla Confections and Arise Bioscience Inc.

Highlights

• Multi-state operator in the U.S.; nationwide distributor of hemp-derived CBD products; Canadian LP with global distribution; and drug development and R&D platform
• Seven U.S. cultivation and production facilities , 32 operating dispensaries and 10 premium brands
• Management comprised of leaders from healthcare, pharmaceutical, banking, cannabis, online grocery industries and CPG
• Strategic investors include Canopy Growth, Canopy Rivers, and JW Funds
• $80.5 million loan from strategic partner Canopy Growth
• Unique ability to sell THC and CBD products within Canada and the U.S.through TerrAscend’s manufacturing footprint
• Brand portfolio including premium cannabis Haven St., Valhalla Premium Edibles, Funky Farms, Original Hemp, State Flower, Ilera, Kind Tree, Legend and Prism

Growth Strategy

• Multi-state operator (MSO) in the U.S. focused on key markets: California, Michigan, Pennsylvania, New Jersey and Maryland
• Canadian LP concentrating on production and manufacturing of cannabinoid products for medical and adult-use consumers; footprint in 10 provinces
• Focus on developing protectable intellectual property assets
• Creating quality brands that resonate with patients and consumers
• Plans to leverage The Apothecarium Dispensary brand and store model across the U.S.
• U.S. nationwide distribution of hemp-derived CBD products through Arise Bioscience; access to 10,000+ stores
• Entrance into the Michigan market with full vertical integration through the acquisition of Gage Cannabis; 34 planned dispensaries in the combined footprint
• Strengthened Michigan footprint with the acquisition of Pinnacle

Differentiators

• Proven consolidator with M&A expertise in the highly fragmented U.S. cannabis industry
• First operator with scaled operations in both the U.S. and Canada
• One of 12 vertically integrated entities in New Jersey; ability for 240,000 square feet of production and cultivation space and three retail licenses
• Top wholesale market share in Pennsylvania’s limited license market via Ilera Healthcare; 144,000 square feet of production and cultivation space and six operating dispensaries; distributes to 100% of the state’s medical cannabis dispensaries
• 20,000 square feet of cultivation and production space, five open dispensaries in California market
• Bringing Cookies branded products to New Jersey, Michigan, Pennsylvania and Toronto

Glenn. G. Mattson
Ladenburg Thalmann

Eric Des Lauriers, CFA
Craig-Hallum Capital Group

Russell Stanley
Beacon Securities Limited

Noel Atkinson
Clarus Securities

Pablo Zuanice
Cantor Fitzgerald

Kenric S. Tyghe
AltaCorp Capital

Matt McGinley
Needham

Andrew Partheniou
Stifel | GMP

Andrew Semple
Echelon

Vivien Azer
Cowen